This morning we watched Elanco Animal Health rise 1.5% to a price of $22.58 per share. The Large-Cap Pharmaceutical company is now trading -6.24% below its average target price of $24.08. Analysts have set target prices ranging from $18.0 to $27.0 per share for Elanco Animal Health, and have given the stock an average rating of buy.
Elanco Animal Health has an average level of shares sold short, at 6.1% of its total share float. The stock's short ratio (also called days to cover) is 4.44. The company's insiders own 1.05% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Institutional investors own 116.2% of Elanco Animal Health's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Elanco Animal Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-09-30 | Dodge & Cox Inc. | 17% | 82,759,837 | $1,868,717,113 |
| 2025-09-30 | FMR, LLC | 13% | 65,357,380 | $1,475,769,635 |
| 2025-09-30 | Primecap Management Company | 10% | 49,958,156 | $1,128,055,158 |
| 2025-09-30 | Vanguard Group Inc | 10% | 48,586,708 | $1,097,087,862 |
| 2025-09-30 | Blackrock Inc. | 9% | 46,178,502 | $1,042,710,571 |
| 2025-09-30 | T. Rowe Price Investment Management, Inc. | 6% | 31,510,014 | $711,496,113 |
| 2025-09-30 | Dimensional Fund Advisors LP | 5% | 24,708,676 | $557,921,902 |
| 2025-09-30 | UBS Group AG | 3% | 16,468,148 | $371,850,780 |
| 2025-09-30 | State Street Corporation | 3% | 15,245,783 | $344,249,778 |
| 2025-09-30 | Black Creek Investment Management Inc. | 3% | 12,482,461 | $281,853,968 |
